More recently, Biovail said that a US federal grand jury is investigating activities surrounding the 2003 launch of Cardizem LA, a major initiative while ...
... to $13.25 after the company said it is the target of US federal grand jury investigation into the 2003 commercial launch of its Cardizem heart drug. ...
Monitors special drugs (ie, Dopamine, Lidocaine, Dobutrex, and Cardizem) and other cardiac drugs, as per protocol. E7. Assesses patients in an on going ...
... traded drug maker, said Friday it is the target of a US federal grand jury investigation over the 2003 launch of its hypertension drug Cardizem LA. ...
... the company's officers and directors lied about the effectiveness of its Cardizem LA drug for high blood pressure when it was introduced in 2003. ...
N: Quote, Profile, Research) said on Friday that it is being investigated by a US Federal grand jury concerning the 2003 commercial launch of its Cardizem ...
Biovail Corp. said earlier this month that it is being investigated by a US Federal grand jury concerning the 2003 commercial launch of its Cardizem LA ...
N: Quote, Profile, Research) said on Friday that it is being investigated by a US Federal grand jury concerning the 2003 commercial launch of its Cardizem ...
N: Quote, Profile, Research) said on Friday that it is being investigated by a US Federal grand jury concerning the 2003 commercial launch of its Cardizem ...
Biovail said the fee was compensation for the doctors' efforts in submitting data on their patients, needed for the full launch of Cardizem LA. ...